Company / Current Liabilities per Share
Monte Rosa Therapeutics, Inc. Current Liabilities per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$2.12
FY2024
5-year range
$0.54 / $19.30
FY2020-FY2024
Trend
+134.2%
vs FY2023
Sector context
#65 of 210
Health Care
What the data says
At $2.12, Monte Rosa Therapeutics, Inc.'s current liabilities per share ranks #146 of 210 in the Health Care sector. Increased from $0.54 to $2.12 over the past 2 years.
Based on SEC 10-K filings.
2.12 in FY2024 with a 3-year CAGR of +47.2%.
Increased from $0.54 to $2.12 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +47.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#146 of 210 in Health CareTop 69% of 210This company $2.12 Sector average $23.79
▼
-91.1% below sector average
Key checks
Key Insights
- In FY2024, current liabilities per share increased 134.2% year-over-year.
- Ranks #65 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2020.
- Lowest current liabilities per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.12 | +134.2% |
| FY2023 | $0.91 | +67.4% |
| FY2022 | $0.54 | -18.6% |
| FY2021 | $0.67 | -96.6% |
| FY2020 | $19.30 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026